重症成人营养管理指南推荐意见的证据质量评价
本研究从官方网站下载2019年欧洲临床营养与代谢学会(ESPEN)和2016年美国肠外肠内营养学会(ASPEN)重症患者医学营养治疗指南,将证据等级和推荐强度标准化为GRADE系统,证据质量分为高质量(无重要局限的随机对照试验)、中等质量(降级的随机对照试验或升级的观察性研究)或低质量(无特殊优势或重要局限的观察性研究、病例系列、病例报告),并纳入良好实践点(GPP,基于指南制定组临床经验的推荐),推荐强度分为强或弱。共152条推荐中仅5条(3.3%)由高质量证据支持,14条为强推荐,79条(52.0%)为GPP。ESPEN指南中高质量证据(7% vs 1.1%,p<0.05)和中等质量证据(33.3% vs 8.4%,p<0.01)支持的推荐比例均显著高于ASPEN;ASPEN指南中GPP支持的推荐比例更高(58.9% vs 40.4%,p=0.03);在肠内与肠外营养方面,ESPEN指南中中等质量证据支持的推荐比例显著更高(50% vs 15.8%,p<0.01)。作者结论认为,已发表的重症成人营养管理指南推荐仍大多由专家意见支持,仅少数由高质量证据支持,亟需高质量临床试验。
要点
- 152条ESPEN与ASPEN重症营养推荐中仅5条(3.3%)由高质量证据支持,14条为强推荐。
- 79条(52.0%)推荐为良好实践点(GPP),即基于指南制定组临床经验。
- ESPEN较ASPEN有更高比例的高质量证据推荐(7% vs 1.1%,p<0.05)和中等质量证据推荐(33.3% vs 8.4%,p<0.01)。
- ASPEN较ESPEN有更高比例的GPP推荐(58.9% vs 40.4%,p=0.03)。
- 肠内与肠外营养方面,ESPEN较ASPEN有更高比例的中等质量证据推荐(50% vs 15.8%,p<0.01)。
适用人群与场景
- 重症成人患者的医学营养治疗。
研究设计与关键结果
- 研究类型为对指南推荐意见的证据质量评价,评价对象为2019年ESPEN和2016年ASPEN重症患者医学营养治疗指南,共152条推荐。
- 仅5条(3.3%)推荐由高质量证据支持,14条为强推荐,79条(52.0%)为良好实践点(GPP)。
- ESPEN vs ASPEN:高质量证据支持的推荐比例为7% vs 1.1%(p<0.05),中等质量证据支持的推荐比例为33.3% vs 8.4%(p<0.01),GPP比例为40.4% vs 58.9%(p=0.03,ASPEN更高)。
- 肠内与肠外营养方面,中等质量证据支持的推荐比例为ESPEN 50% vs ASPEN 15.8%(p<0.01)。
证据类型、等级与局限
- 证据类型:对指南推荐意见的证据质量评价;证据等级按GRADE系统标准化为高质量、中等质量、低质量,并纳入良好实践点(GPP),推荐强度分为强或弱。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,已发表的重症成人营养管理指南推荐仍大多由专家意见支持,仅少数由高质量证据支持,亟需高质量临床试验。
指南或共识出处
- 2019年欧洲临床营养与代谢学会(ESPEN)重症患者医学营养治疗指南;2016年美国肠外肠内营养学会(ASPEN)重症患者医学营养治疗指南。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIMS: The primary aim of this study was to evaluate the quality of evidence supporting the 2019 European Society for Clinical Nutrition and Metabolism (ESPEN) and 2016 American Society for Parenteral and Enteral Nutrition (ASPEN) recommendations for medical nutrition therapy in critically ill patients. Secondary objectives are to assess the differences between 2019 ESPEN and 2016 ASPEN recommendations and to inform relevant stakeholders of areas requiring improvement in the research.
METHODS: The 2019 ESPEN and 2016 ASPEN guidelines were identified and downloaded from the official websites. The level of evidence and strength of recommendations from the guidelines were standardised to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system. Level of evidence was classified as high-quality (randomised controlled trials (RCTs) without important limitations), moderate-quality (downgraded RCTs or upgraded observational studies) or low-quality (observational studies without specific strengths or important limitations, case series, case reports). In addition, good practice points (GPP; recommendations based on the clinical experience of the guideline development group) were considered. Strength of recommendation was reported as strong or weak.
RESULTS: From 152 total recommendations, only five (3.3%) were supported by high-quality evidence, with 14 being strong recommendations. A total of 79 (52.0%) recommendations were GPPs. Overall, the proportion of recommendations supported by high-quality (7% [ESPEN] vs. 1.1% [ASPEN], p < 0.05) and moderate-quality evidence (33.3% [ESPEN] vs. 8.4% [ASPEN], p < 0.01) was significantly higher in ESPEN guidelines. On the other hand, ASPEN guidelines reported a greater proportion of recommendations supported by GPPs (58.9% [ASPEN] vs. 40.4% [ESPEN], p = 0.03). In enteral and parenteral nutrition, the proportion of recommendations supported by moderate-quality evidence (50% [ESPEN] vs. 15.8% [ASPEN], p < 0.01) was significantly higher in ESPEN guidelines.
CONCLUSION: Published guideline recommendations for the nutritional management of critically ill adults remain largely supported by expert opinion and only a minority by high-quality evidence. An urgent unmet clinical need for high-quality clinical trials is warranted.
参考来源
- Xu E, Tejada S, Solé-Lleonart C, et al. Evaluation of the quality of evidence supporting guideline recommendations for the nutritional management of critically ill adults. Clin Nutr ESPEN. 2020. PMID: 32859308. doi:10.1016/j.clnesp.2020.07.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。